Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Seri | - |
dc.contributor.author | Yang, Dahae | - |
dc.contributor.author | Lee, Woonhyoung | - |
dc.contributor.author | Kim, Geun-Tae | - |
dc.contributor.author | Kim, Hyon-Suk | - |
dc.contributor.author | Ahn, Hyeong Sik | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.date.accessioned | 2021-09-02T06:08:19Z | - |
dc.date.available | 2021-09-02T06:08:19Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 0049-0172 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/73007 | - |
dc.description.abstract | Objective: This study aimed to review and compare the diagnostic accuracy of the screening enzyme immunoassay (SEIA) and indirect immunofluorescence (IIF) as anti-nuclear antibody (ANA) screening assays for patients with systemic rheumatic diseases (SRDs), including systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and systemic sclerosis (SSc). Methods: A systematic literature search was conducted in the Medline, Embase, Cochrane, Web of Science, and Scopus databases for articles published before August 2017. A bivariate random effects model was used to calculate pooled diagnostic values. Results: Thirty-three studies including 3976 combined SRDs, 2839 SLE, 610 SS, and 1002 SSc patients and 11,716 non-healthy and 8408 healthy controls were available for the meta-analysis. The summary sensitivities of SEIA vs. IIF were 87.4% vs 88.4% for combined SRDs, 89.4% vs. 95.2% for SLE, 88.7% vs. 88.4% for SS, and 85.4% vs. 93.6% for SSc, respectively. Meanwhile, the summary specificities of SEIA vs. IIF were 79.7% vs.78.9% for combined SRDs, 89.1% vs. 83.3% for SLE, 89.9% vs. 86.8% for SS, and 92.8% vs. 84.2% for SSc, respectively. Although the differences in sensitivity and specificity between SEIA and IIF were not significant in most subgroups, the summary sensitivity of SLE presented statistically significant changes. Conclusions: Our systematic meta-analysis demonstrates that both SEIA and IIF are useful to detect ANAs for SRDs. Between the two assays, IIF is a more sensitive screening assay than SEIA, particularly in patients with SLE. SEIA is comparable to IIF, considering the specificity and standardization. (C) 2018 Published by Elsevier Inc. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.subject | HEP-2 CELL EXTRACT | - |
dc.subject | CLASSIFICATION CRITERIA | - |
dc.subject | RECOMBINANT ANTIGENS | - |
dc.subject | SJOGRENS-SYNDROME | - |
dc.subject | AMERICAN-COLLEGE | - |
dc.subject | REVISED CRITERIA | - |
dc.subject | ASSAY | - |
dc.subject | TESTS | - |
dc.subject | PERFORMANCE | - |
dc.subject | ELISA | - |
dc.title | Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Hyeong Sik | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Jung | - |
dc.identifier.doi | 10.1016/j.semarthrit.2018.01.011 | - |
dc.identifier.scopusid | 2-s2.0-85044508026 | - |
dc.identifier.wosid | 000450244700021 | - |
dc.identifier.bibliographicCitation | SEMINARS IN ARTHRITIS AND RHEUMATISM, v.48, no.2, pp.334 - 342 | - |
dc.relation.isPartOf | SEMINARS IN ARTHRITIS AND RHEUMATISM | - |
dc.citation.title | SEMINARS IN ARTHRITIS AND RHEUMATISM | - |
dc.citation.volume | 48 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 334 | - |
dc.citation.endPage | 342 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | HEP-2 CELL EXTRACT | - |
dc.subject.keywordPlus | CLASSIFICATION CRITERIA | - |
dc.subject.keywordPlus | RECOMBINANT ANTIGENS | - |
dc.subject.keywordPlus | SJOGRENS-SYNDROME | - |
dc.subject.keywordPlus | AMERICAN-COLLEGE | - |
dc.subject.keywordPlus | REVISED CRITERIA | - |
dc.subject.keywordPlus | ASSAY | - |
dc.subject.keywordPlus | TESTS | - |
dc.subject.keywordPlus | PERFORMANCE | - |
dc.subject.keywordPlus | ELISA | - |
dc.subject.keywordAuthor | Anti-nuclear antibody | - |
dc.subject.keywordAuthor | Immunoassay | - |
dc.subject.keywordAuthor | Indirect immunofluorescence | - |
dc.subject.keywordAuthor | Screening | - |
dc.subject.keywordAuthor | Systemic lupus erythematosus | - |
dc.subject.keywordAuthor | Systemic rheumatic disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.